{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T17:10:09Z","timestamp":1741194609064,"version":"3.38.0"},"reference-count":38,"publisher":"JLE","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.nephro.2017.11.007","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T03:41:03Z","timestamp":1529379663000},"page":"233-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Vaccinations des patients adultes atteints d\u2019une maladie r\u00e9nale"],"prefix":"10.1684","volume":"15","author":[{"given":"Claire","family":"Trivin-Avillach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9ric","family":"Thervet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2017.11.007_bib0005","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrneph.2013.44","article-title":"Immune cell dysfunction and inflammation in end-stage renal disease","volume":"9","author":"Betjes","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.nephro.2017.11.007_bib0010","doi-asserted-by":"crossref","first-page":"8415179","DOI":"10.1155\/2017\/8415179","article-title":"Increased neutrophil extracellular trap formation in uremia is associated with chronic inflammation and prevalent coronary artery disease","volume":"2017","author":"Kim","year":"2017","journal-title":"J Immunol Res"},{"key":"10.1016\/j.nephro.2017.11.007_bib0015","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/sj.ki.5001550","article-title":"Na\u00efve and central memory T-cell lymphopenia in end-stage renal disease","volume":"70","author":"Yoon","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2017.11.007_bib0020","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1523-1755.2004.00781.x","article-title":"Peripheral blood dendritic cells and GM-CSF as an adjuvant for hepatitis\u00a0B vaccination in hemodialysis patients","volume":"66","author":"Verkade","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2017.11.007_bib0025","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00467-008-0782-5","article-title":"High serological response to pneumococcal vaccine in nephrotic children at disease onset on high-dose prednisone","volume":"23","author":"Ulinski","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nephro.2017.11.007_bib0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1067\/mpd.2003.37","article-title":"Varicella vaccination in children with nephrotic syndrome: a report of the Southwest Pediatric Nephrology Study Group","volume":"142","author":"Furth","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.nephro.2017.11.007_bib0035","first-page":"CD003964","article-title":"Interventions for preventing infection in nephrotic syndrome","volume":"4","author":"Wu","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"year":"2017","series-title":"Calendrier des vaccinations et recommandations vaccinales 2017","author":"Minist\u00e8re des Affaires sociales et de la Sant\u00e9","key":"10.1016\/j.nephro.2017.11.007_bib0040"},{"key":"10.1016\/j.nephro.2017.11.007_bib0045","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.vaccine.2011.11.109","article-title":"Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review","volume":"30","author":"Agarwal","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.nephro.2017.11.007_bib0050","first-page":"1118","article-title":"Pneumococcal immunization in patients with systemic lupus erythematosus treated with immunosuppressives","volume":"12","author":"Lipnick","year":"1985","journal-title":"J Rheumatol"},{"year":"2015","series-title":"Vaccination des personnes immunod\u00e9prim\u00e9es ou aspl\u00e9niques. Recommandations actualis\u00e9es","author":"Haut Conseil de la sant\u00e9 publique","key":"10.1016\/j.nephro.2017.11.007_bib0055"},{"issue":"66","key":"10.1016\/j.nephro.2017.11.007_bib0060","first-page":"S806","article-title":"Safety of zoster vaccination administration in rheumatic patients on current biologic therapy","author":"Lindsey","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.nephro.2017.11.007_bib0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ajh.22196","article-title":"Experience with use of Zostavax\u00ae in patients with hematologic malignancy and hematopoietic cell transplant recipients","volume":"87","author":"Naidus","year":"2012","journal-title":"Am J Hematol"},{"year":"2017","series-title":"Immunizations in solid organ transplant candidates and recipients \u2013\u00a0UpToDate","author":"Hibberd","key":"10.1016\/j.nephro.2017.11.007_bib0070"},{"key":"10.1016\/j.nephro.2017.11.007_bib0075","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/rheumatology\/ker389","article-title":"Protective effect of A\/H1N1\u00a0vaccination in immune-mediated disease \u2013\u00a0a prospectively controlled vaccination study","volume":"51","author":"Adler","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.nephro.2017.11.007_bib0080","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.vaccine.2010.12.072","article-title":"The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab","volume":"29","author":"Arad","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.nephro.2017.11.007_bib0085","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1186\/ar3047","article-title":"Vaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatment","volume":"12","author":"Rehnberg","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.nephro.2017.11.007_bib0090","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/art.25033","article-title":"Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab","volume":"62","author":"van Assen","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.nephro.2017.11.007_bib0095","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/ard.2007.077461","article-title":"Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response","volume":"67","author":"Oren","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.nephro.2017.11.007_bib0100","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/art.25034","article-title":"Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial","volume":"62","author":"Bingham","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.nephro.2017.11.007_bib0105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11926-015-0539-7","article-title":"B\u00a0cell therapies, approved and emerging: a review of infectious risk and prevention during use","volume":"17","author":"Yusof","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.nephro.2017.11.007_bib0110","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1385\/MO:19:2:71","article-title":"Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae","volume":"19","author":"Nord\u00f8y","year":"2002","journal-title":"Med Oncol"},{"key":"10.1016\/j.nephro.2017.11.007_bib0115","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1016\/j.vaccine.2012.08.074","article-title":"Revaccination with Fendrix\u00ae or HBVaxPro\u00ae results in better response rates than does revaccination with three doses of Engerix-B\u00ae in previous non-responders","volume":"30","author":"Hoebe","year":"2012","journal-title":"Vaccine"},{"year":"2017","series-title":"Vaccins contre les h\u00e9patites\u00a0A et\u00a0B\u00a0: tensions d\u2019approvisionnement","author":"Haut Conseil de la sant\u00e9 publique","key":"10.1016\/j.nephro.2017.11.007_bib0120"},{"year":"2014","series-title":"Vaccination contre l\u2019h\u00e9patite\u00a0B\u00a0: probl\u00e9matique des non-r\u00e9pondeurs","author":"Haut Conseil de la sant\u00e9 publique","key":"10.1016\/j.nephro.2017.11.007_bib0125"},{"key":"10.1016\/j.nephro.2017.11.007_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2567.2003.01716.x","article-title":"Potential role of soluble CD40\u00a0in the humoral immune response impairment of uraemic patients","volume":"110","author":"Contin","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.nephro.2017.11.007_bib0135","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(83)90624-4","article-title":"Prevention of perinatally transmitted hepatitis\u00a0B virus infections with hepatitis\u00a0B immune globulin and hepatitis\u00a0B vaccine","volume":"2","author":"Beasley","year":"1983","journal-title":"Lancet"},{"year":"2016","series-title":"Guide pour l\u2019immunisation en postexposition\u00a0: vaccination et immunoglobulines","author":"Haut Conseil de la sant\u00e9 publique","key":"10.1016\/j.nephro.2017.11.007_bib0140"},{"key":"10.1016\/j.nephro.2017.11.007_bib0145","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1600-6143.2007.02066.x","article-title":"Influenza vaccination is efficacious and safe in renal transplant recipients","volume":"8","author":"Scharp\u00e9","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nephro.2017.11.007_bib0150","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.1016\/j.vaccine.2010.08.015","article-title":"Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination","volume":"28","author":"Morelon","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.nephro.2017.11.007_bib0155","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1111\/j.1600-6143.2007.01982.x","article-title":"Immunogenicity and safety of an intradermal boosting strategy for vaccination against influenza in lung transplant recipients","volume":"7","author":"Manuel","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nephro.2017.11.007_bib0160","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/BF00865476","article-title":"Attenuated varicella virus vaccine in children with renal transplants","volume":"8","author":"Zamora","year":"1994","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nephro.2017.11.007_bib0165","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1399-3046.2005.00279.x","article-title":"Seroprevalence of antibodies against varicella-zoster virus and response to the varicella vaccine in pediatric renal transplant patients","volume":"9","author":"Chaves","year":"2005","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.nephro.2017.11.007_bib0170","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1600-6143.2005.01210.x","article-title":"Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients","volume":"6","author":"Weinberg","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nephro.2017.11.007_bib0175","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1111\/j.1600-6143.2012.04273.x","article-title":"Varicella-zoster immunization in pediatric liver transplant recipients: safe and immunogenic","volume":"12","author":"Posfay-Barbe","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nephro.2017.11.007_bib0180","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1111\/ajt.12329","article-title":"Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients","volume":"13","author":"Kumar","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nephro.2017.11.007_bib0185","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00007890-200102150-00023","article-title":"Rapid decline of antibodies after hepatitis\u00a0A immunization in liver and renal transplant recipients","volume":"71","author":"G\u00fcnther","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2017.11.007_bib0190","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1111\/ajt.12338","article-title":"Persistence of yellow fever vaccine-induced antibodies after solid organ transplantation","volume":"13","author":"Wyplosz","year":"2013","journal-title":"Am J Transplant"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725518300051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725518300051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2017.11.007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:15:10Z","timestamp":1741191310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725518300051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1769725518300051"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2017.11.007","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccinations des patients adultes atteints d\u2019une maladie r\u00e9nale","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2017.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Soci\u00e9t\u00e9 francophone de n\u00e9phrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}